CAR-T cells can eradicate human uveal melanoma and immune-therapy resistant malignant melanoma in IL-2 transgenic NOD/SCID IL2 receptor gamma knockout mice

被引：1
|
作者：
Forsberg, Elin [1 ]
Lindberg, Mattias [1 ]
Jespersen, Henrik [1 ]
Alsen, Samuel [1 ]
Bagge, Roger Olofsson [1 ]
Donia, Marco [2 ]
Svane, Inge Marie [2 ]
Nilsson, Ola [1 ]
Ny, Lars [1 ]
Nilsson, Lisa [1 ]
Nilsson, Jonas [1 ]
机构：
[1] Sahlgrenska Canc Ctr, Gothenburg, Sweden
[2] Ctr Canc Immunotherapy, Herlev, Denmark
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3185
引用
收藏
页数：2
相关论文
共 22 条
  • [1] HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
    Forsberg, Elin M. V.
    Lindberg, Mattias F.
    Jespersen, Henrik
    Alsen, Samuel
    Bagge, Roger Olofsson
    Donia, Marco
    Svane, Inge Marie
    Nilsson, Ola
    Ny, Lars
    Nilsson, Lisa M.
    Nilsson, Jonas A.
    CANCER RESEARCH, 2019, 79 (05) : 899 - 904
  • [2] In vivo reconstitution of human natural T regulatory cells in NOD/SCID IL2γcnull mice by expression of human IL-2
    Abraham, Sojan
    Pahwa, Rajendra
    Ye, Chunting
    Pahwa, Savita
    Jaggaiahgari, Shashidhar
    Manjunath, N.
    Shankar, Premlata
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [3] Expression and function of IL-2 receptor on human uveal melanoma cells
    He, YG
    Mayhew, E
    Niederkorn, JY
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U504 - U504
  • [4] Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
    Ishikawa, F
    Yasukawa, M
    Lyons, B
    Yoshida, S
    Miyamoto, T
    Yoshimoto, G
    Watanabe, T
    Akashi, K
    Shultz, LD
    Harada, M
    BLOOD, 2005, 106 (05) : 1565 - 1573
  • [5] Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research
    Shultz, Leonard D.
    Pearson, Todd
    King, Marie
    Giassi, Lisa
    Carney, Lisa
    Gott, Bruce
    Lyons, Bonnie
    Rossini, Aldo A.
    Greiner, Dale L.
    HOW DO WE BEST EMPLOY ANIMAL MODELS FOR TYPE 1 DIABETES AND MULTIPLE SCLEROSIS?, 2007, 1103 : 77 - 89
  • [6] IMMUNE DYSFUNCTIONS AND ACTIVATION OF NATURAL-KILLER-CELLS IN HUMAN IL-2 AND IL-2/IL-2 RECEPTOR L-CHAIN TRANSGENIC MICE
    ISHIDA, Y
    NISHI, M
    TAGUCHI, O
    INABA, K
    MINATO, N
    KAWAICHI, M
    HONJO, T
    IMMUNOLOGICAL RECOGNITION, PTS 1 AND 2, 1989, 54 : 695 - 704
  • [7] IMMUNE DYSFUNCTIONS AND ACTIVATION OF NATURAL-KILLER-CELLS IN HUMAN IL-2 AND IL-2/IL-2 RECEPTOR L-CHAIN TRANSGENIC MICE
    ISHIDA, Y
    NISHI, M
    TAGUCHI, O
    INABA, K
    MINATO, N
    KAWAICHI, M
    HONJO, T
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1989, 54 : 695 - 704
  • [8] Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγcnull Mice by Expression of Human IL-2
    Abraham, Sojan
    Pahwa, Rajendra
    Ye, Chunting
    Choi, Jang-gi
    Pahwa, Savita
    Jaggaiahgari, Shashidhar
    Raut, Ashwin
    Chen, Shuiping
    Manjunath, N.
    Shankar, Premlata
    PLOS ONE, 2012, 7 (12):
  • [9] IL-2 CAN SUPPORT GROWTH OF CD8(+) T-CELLS BUT NOT CD4(+) T-CELLS OF HUMAN IL-2 RECEPTOR BETA-CHAIN TRANSGENIC MICE
    ASANO, M
    ISHIDA, Y
    SABE, H
    KONDO, M
    SUGAMURA, K
    HONJO, T
    JOURNAL OF IMMUNOLOGY, 1994, 153 (12): : 5373 - 5381
  • [10] Involvement of CXCR4 and IL-2 in the homing of human NK and NK T cells to the bone marrow of NOD/SCID mice.
    Peled, A
    Beider, K
    Wald, O
    Franitza, S
    Dagan, M
    Wald, H
    Giladi, H
    Galun, E
    Brocke, S
    Nagler, A
    BLOOD, 2002, 100 (11) : 397B - 397B
123